Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - R1 RCM INC. | c61258exv99w1.htm |
| EX-99.2 - EX-99.2 - R1 RCM INC. | c61258exv99w2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 11, 2010
Accretive Health, Inc.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 001-34746 | 02-0698101 | ||
| (State or Other Juris- diction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 401 North Michigan Avenue, Suite 2700, Chicago, Illinois | 60611 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (312) 324-7820
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. Results of Operations and Financial Condition.
On November 11, 2010, Accretive Health, Inc. (the “Company”) announced its financial results for
the quarter ended September 30, 2010. The full text of the press release issued in connection with
the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
In addition, on November 11, 2010, the Company held a publicly available live webcast discussion of
its financial results for the quarter ended September 30, 2010. The transcript of the conference
call is furnished as Exhibit 99.2 to this Current Report on Form 8-K.
The information in this Form 8-K (including Exhibits 99.1 and 99.2) shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by
specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following exhibits relating to Item 2.02 shall be deemed to be furnished, and not filed:
99.1
|
Press Release issued by the Company on November 11, 2010 | |
99.2
|
Transcript of conference call held by the Company on November 11, 2010 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ACCRETIVE HEALTH, INC. |
||||
| Date: November 17, 2010 | By: | /s/ John T. Staton | ||
| John T. Staton | ||||
| Chief Financial Officer and Treasurer | ||||
EXHIBIT INDEX
| Exhibit No. | Description | |
99.1
|
Press Release issued by the Company on November 11, 2010 | |
99.2
|
Transcript of conference call held by the Company on November 11, 2010 |